Activation of rat mast cells upon stimulation of protease-activated receptor (PAR-1)

被引：12
|
作者：
Umarova, BA
Dugina, TN
Shestakova, EV
Gluza, E
Strukova, SM
机构：
[1] Moscow MV Lomonosov State Univ, Dept Human & Anim Physiol, Moscow 117234, Russia
[2] Univ Jena, Ctr Vasc Surg & Med, Erfurt, Germany
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2000年 / 129卷 / 04期
关键词：
mast cells; proteolytically cleaved receptor; thrombin; beta-hexosaminidase; heparin;
D O I：
10.1007/BF02439253
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
In vivo experiments on the model of wound healing showed that thrombin and thrombin receptor agonist TRAP-6 stimulated heparin secretion by mast cells in rat subcutaneous fat: the saturation of mast cells with heparin decreased, while degranulation and granulolysis increased. In vitro studies showed that TRAP-6 caused a dose-dependent release of beta-hexosaminidase from peritoneal mast cells. TRAP-6 also induced heparin release from these cells and inhibition of amidase activity of thrombin. Heparin released from mast cells had low anticoagulant activity. These data suggest that activation of mast cells with thrombin is mediated by PAR-1.
引用
收藏
页码：314 / 317
页数：4
相关论文
共 50 条
  • [31] Thrombin stimulates procollagen α1(I) gene transcription via protease-activated receptor-1 (PAR-1).
    Chambers, RC
    Asano, M
    Garcia, P
    Goldsack, NR
    Blanc-Brude, O
    Dabbagh, K
    Laurent, GJ
    FASEB JOURNAL, 1999, 13 (05): : A853 - A853
  • [32] Protease-activated receptor-3 (PAR-3) expression, regulation and PAR-1 independent function in human vascular smooth muscle cells
    Rosenkranz, A. C.
    Rauch, B. H.
    Doller, A.
    Eberhardt, W.
    Schroer, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 11 - 11
  • [33] In glial cells two types of protease-activated receptors (PAR-1 and PAR-2) are coupled to calcium mobilization.
    Ubl, JJ
    Vöhringer, C
    Reiser, G
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 338 - 338
  • [34] Protease Activated Receptor-1 (PAR-1) Impedes Tumor Progression
    Adams, Gregory N.
    Weston, Haley
    Rosenfeldt, Leah
    Frederick, Malinda
    Palumbo, Joseph S.
    BLOOD, 2016, 128 (22)
  • [35] Cleavage of protease-activated receptor 1(PAR-1) by a platelet protease and thrombin: Modulation by soybean trypsin inhibitor, glycoprotein IB(GPIB), and anti-protease-activated receptor antibodies.
    Ofosu, FA
    Fenton, JW
    Freedman, J
    TRANSFUSION, 2000, 40 (10) : 104S - 104S
  • [36] Pharmacologic Profile of SCH 530348, a Novel Oral Antiplatelet Agent Selective for the Protease-Activated Receptor-1 (PAR-1)
    Chintala, Madhu
    Ahn, Ho-Sam
    Foster, Carolyn
    Agans, Jacqueline
    Boykow, George
    CIRCULATION, 2008, 118 (18) : S374 - S374
  • [37] Protease-activated receptor-1 (PAR-1) increases intracellular calcium and mediates chloride secretion in an epithelial cell line
    Buresi, MC
    Schleihauf, E
    Vergnolle, N
    Chapman, K
    Buret, A
    Wallace, JL
    Hollenberg, MD
    MacNaughton, WK
    FASEB JOURNAL, 2000, 14 (04): : A114 - A114
  • [38] Protease-Activated Receptor 1 (PAR-1) Inhibits Proliferation but Enhances Leukemia Stem Cell Activity in Acute Myeloid Leukemia
    Goyama, Susumu
    Shrestha, Mahesh
    Schibler, Janet
    Rosenfeldt, Leah
    Miller, Whitney
    O'Brien, Eric
    Mizukawa, Benjamin
    Kitamura, Toshio
    Palumbo, Joseph S.
    Mulloy, James C.
    BLOOD, 2016, 128 (22)
  • [39] Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients
    Sanjay Goyal
    Ankita Sood
    Isha Gautam
    Soumyadip Pradhan
    Puskar Mondal
    Gaaminepreet Singh
    Ravinder Singh Jaura
    Thakur Gurjeet Singh
    Raminderpal Singh Sibia
    Inflammopharmacology, 2022, 30 : 1843 - 1851
  • [40] Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients
    Goyal, Sanjay
    Sood, Ankita
    Gautam, Isha
    Pradhan, Soumyadip
    Mondal, Puskar
    Singh, Gaaminepreet
    Jaura, Ravinder Singh
    Singh, Thakur Gurjeet
    Sibia, Raminderpal Singh
    INFLAMMOPHARMACOLOGY, 2022, 30 (05) : 1843 - 1851
12345